[C:1]([O:4][CH2:5][C:6]1[C:11](B2OC(C)(C)C(C)(C)O2)=[CH:10][CH:9]=[CH:8][C:7]=1[N:21]1[N:30]=[CH:29][C:28]2[C:23](=[C:24]([F:35])[CH:25]=[C:26]([C:31]([CH3:34])([CH3:33])[CH3:32])[CH:27]=2)[C:22]1=[O:36])(=[O:3])[CH3:2].[N:37]1([CH2:41][C:42]2[N:46]([CH3:47])[N:45]=[C:44]([NH:48][C:49]3[C:50](=[O:57])[N:51]([CH3:56])[N:52]=[C:53](Cl)[CH:54]=3)[CH:43]=2)[CH2:40][CH2:39][CH2:38]1.P([O-])([O-])([O-])=O.[K+].[K+].[K+].C1(P(C2CCCCC2)C2C=CC=CC=2C2C(C(C)C)=CC(C(C)C)=CC=2C(C)C)CCCCC1.[Cl-].[NH4+]>C(O)CCC.O>[N:37]1([CH2:41][C:42]2[N:46]([CH3:47])[N:45]=[C:44]([NH:48][C:49]3[C:50](=[O:57])[N:51]([CH3:56])[N:52]=[C:53]([C:11]4[CH:10]=[CH:9][CH:8]=[C:7]([N:21]5[N:30]=[CH:29][C:28]6[C:23](=[C:24]([F:35])[CH:25]=[C:26]([C:31]([CH3:33])([CH3:34])[CH3:32])[CH:27]=6)[C:22]5=[O:36])[C:6]=4[CH2:5][O:4][C:1](=[O:3])[CH3:2])[CH:54]=3)[CH:43]=2)[CH2:40][CH2:39][CH2:38]1A solution of 2-(6-tert-butyl-8-fluoro-1-oxophthalazin-2(1H)-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl acetate (498 mg, 1.01 mmol), 4-(5-(azetidin-1-ylmethyl)-1-methyl-1H-pyrazol-3-ylamino)-6-chloro-2-methylpyridazin-3(2H)-one (183 mg, 0.59 mmol), potassium phosphate (315 mg, 1.48 mmol) and dicyclohexyl(2′,4′,6′-triisopropylbiphenyl-2-yl)phosphine (28.3 mg, 0.06 mmol) in butanol (4 ml) and water (1 mL) was flushed with argon before (bis[dibenzylideneacetone]dipalladium) (17.0 mg, 0.03 mmol) was added and the resulting solution heated at 100° C. in for 2 h. The resulting mixture was cooled, poured into a saturated solution of ammonium chloride and extracted with methylene chloride (2×100 mL). The layers were separated and the organic phase dried over magnesium sulfate. The mixture was filtered and concentrated in vacuo. The residue was dissolved in dioxane (10 mL) and treated with a lithium hydroxide solution (0.5 mL, 2.0 M), and the resulting mixture was stirred at room temperature overnight. The resulting mixture was poured into a saturated ammonium chloride solution and extracted with methylene chloride (2×150 mL). The layers were separated and the organic phase dried over magnesium sulfate. The mixture was filtered and concentrated in vacuo. The residue was purified by flash chromatography (silica gel, 24 g, 1% to 10% methanol in dichloromethane) to give acetic acid 2-[5-(5-azetidin-1-ylmethyl-1-methyl-1H-pyrazol-3-ylamino)-1-methyl-6-oxo-1,6-dihydro-pyridazin-3-yl]-6-(6-tert-butyl-8-fluoro-1-oxo-1H-phthalazin-2-yl)-benzyl ester (112 mg, 32%) as an off white solid: mp. 214-217° C.; 1H NMR (300 MHz, DMSO-d6) δ ppm 1.01-1.55 (m, 10H) 1.72-2.08 (m, 2H) 2.90-3.67 (m, 11H) 4.28-4.62 (m, 3H) 6.08 (s, 1H) 7.22-8.08 (m, 6H) 8.50 (d, J=1.89 Hz, 1H) 9.15 (s, 1H).
불러오는 중…